Rheumatoid Arthritis Advisor

Researchers found that using genes as biomarkers to identify the optimal therapy might potentially someday benefit patients with rheumatoid arthritis.

Investigators continue to find advanced radiologic imaging techniques for surgeons to use during interventions in cervical spine involvement in rheumatoid arthritis.

Physicians interviewed by Rheumatology Advisor recommend using the Clinical Disease Activity Index and to treat-to-target by measuring clinical response and adapting therapy rapidly for patients with rheumatoid arthritis.

Researchers found data that showed screening, and subsequent statin intervention, is cost-effective and cost-saving, which might be increased by identifying patients with rheumatoid arthritis who are high-risk for cardiovascular disease and in need of preventive therapy.

Researchers found data that showed in patients with rheumatoid arthritis, the delta-tetrahydrocannabinol found in medical cannabis is likely to contribute to an increase in heart rate in patients who are susceptible to atherosclerosis and cardiovascular disease. Medical cannabis was also not found to provide therapeutic effects when comparing it with a combination of cannabinoid type 1 antagonist, fatty acid amide hydrolase inhibitor, and nonpsychotropic cannabidiol.